ES2263361A1 - Method of detecting antibiotic residues and other antimicrobial compounds - Google Patents
Method of detecting antibiotic residues and other antimicrobial compoundsInfo
- Publication number
- ES2263361A1 ES2263361A1 ES200402932A ES200402932A ES2263361A1 ES 2263361 A1 ES2263361 A1 ES 2263361A1 ES 200402932 A ES200402932 A ES 200402932A ES 200402932 A ES200402932 A ES 200402932A ES 2263361 A1 ES2263361 A1 ES 2263361A1
- Authority
- ES
- Spain
- Prior art keywords
- test
- medium
- antimicrobial compounds
- optionally
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 150000001875 compounds Chemical class 0.000 title claims abstract description 22
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 18
- 230000003115 biocidal effect Effects 0.000 title abstract description 3
- 241000193419 Geobacillus kaustophilus Species 0.000 claims abstract description 13
- 238000001514 detection method Methods 0.000 claims abstract description 12
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 8
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 8
- 239000012472 biological sample Substances 0.000 claims abstract description 4
- 238000012360 testing method Methods 0.000 claims description 66
- 244000005700 microbiome Species 0.000 claims description 19
- 230000035945 sensitivity Effects 0.000 claims description 14
- 230000002503 metabolic effect Effects 0.000 claims description 11
- 239000000523 sample Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 238000011534 incubation Methods 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 5
- 239000008272 agar Substances 0.000 claims description 5
- 230000005764 inhibitory process Effects 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 claims description 5
- 238000002835 absorbance Methods 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000002824 redox indicator Substances 0.000 claims description 3
- 239000002696 acid base indicator Substances 0.000 claims description 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 2
- 229960001082 trimethoprim Drugs 0.000 claims description 2
- 238000002798 spectrophotometry method Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 6
- 238000003556 assay Methods 0.000 abstract description 5
- 235000013336 milk Nutrition 0.000 abstract description 5
- 239000008267 milk Substances 0.000 abstract description 5
- 210000004080 milk Anatomy 0.000 abstract description 5
- 235000013372 meat Nutrition 0.000 abstract description 4
- 235000013601 eggs Nutrition 0.000 abstract description 3
- 235000012907 honey Nutrition 0.000 abstract description 3
- 230000002906 microbiologic effect Effects 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 abstract 1
- -1 sulfamides Chemical class 0.000 abstract 1
- 238000010998 test method Methods 0.000 description 15
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 14
- 229960005322 streptomycin Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 6
- 231100000703 Maximum Residue Limit Toxicity 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000004098 Tetracycline Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229940124530 sulfonamide Drugs 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- 241000626621 Geobacillus Species 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Método de detección de residuos de antibióticos y otros compuestos antimicrobianos.Antibiotic residue detection method and other antimicrobial compounds.
Sector Agroalimentario.Food industry.
Esta invención tiene por objeto un nuevo método de ensayo microbiológico para la detección rápida de la presencia o ausencia de residuos de antibióticos y otros compuestos antimicrobianos como sulfamidas en muestras biológicas tales como leche, huevo, carne, miel, suero y orina. Este nuevo método presenta notables ventajas frente a los actuales métodos rápidos de ensayo microbiológicos comercializados con igual o similar objetivo.This invention aims at a new method Microbiological test for rapid presence detection or absence of residues of antibiotics and other compounds antimicrobials such as sulfa drugs in biological samples such as milk, egg, meat, honey, whey and urine. This new method it presents remarkable advantages over the current rapid methods of microbiological assay marketed with the same or similar objective.
Más concretamente, en la invención se ha ideado un nuevo método basado en la inhibición del crecimiento de Geobacillus kaustophilus en presencia de muestras contaminadas con residuos de compuestos antimicrobianos. Este nuevo método de ensayo permite detectar en un plazo de 1 ½ a 4 ½ horas un gran número de antibióticos en concentraciones próximas a los Límites Máximos de Residuos (LMRs) permitidos en alimentos destinados al consumo humano (Directiva 96/23 CEE).More specifically, a new method based on the inhibition of the growth of Geobacillus kaustophilus in the presence of samples contaminated with residues of antimicrobial compounds has been devised in the invention. This new test method allows a large number of antibiotics to be detected in concentrations close to the Maximum Residue Limits (MRLs) allowed in foods intended for human consumption (Directive 96/23 EEC) within a period of 1½ to 4½ hours.
La detección de residuos de medicamentos y, especialmente de antibióticos y sulfamidas en los alimentos, tiene una extraordinaria importancia dadas sus repercusiones en la Salud Pública y sus efectos sobre los procesos tecnológicos de elaboración de los alimentos.Drug residue detection and, especially antibiotics and sulfa drugs in food, it has of extraordinary importance given its repercussions on Health Public and its effects on the technological processes of Food processing
El problema es de tal magnitud que la Unión Europea ha establecido que no podrán destinarse al consumo humano aquellos alimentos cuyo contenido en residuos de sustancias farmacológicas activas supere unos Límites Máximos de Residuos (LMRs), establecidos según la Directiva 96/23 CEE, que marcan en la actualidad las exigencias mínimas para el comercio internacional.The problem is of such magnitude that the Union European has established that they cannot be used for human consumption those foods whose substance residue content Pharmacological agents exceed a Maximum Residue Limits (MRLs), established according to Directive 96/23 EEC, which mark the current minimum requirements for trade international.
En la actualidad, es posible determinar específicamente la presencia de diversos compuestos antimicrobianos, en matrices tanto sólidas como líquidas, mediante técnicas inmunoquímicas, enzimáticas, HPLC, etc., pero por su simplicidad, bajo coste y amplio espectro, las basadas en la inhibición del crecimiento microbiano son las más ampliamente utilizadas. Dentro de este grupo, las técnicas basadas en la colocación de un disco de un material absorbente, empapado en la muestra problema, sobre una placa de agar sembrada con una determinada especie microbiana son las más antiguas. Estos métodos permiten confirmar la presencia de sustancias inhibidoras por la aparición, tras la correspondiente incubación, de un "halo de inhibición" alrededor del disco.At present, it is possible to determine specifically the presence of various compounds antimicrobials, in both solid and liquid matrices, by immunochemical, enzymatic, HPLC techniques, etc., but for their simplicity, low cost and broad spectrum, based on the microbial growth inhibition are the most widely used Within this group, techniques based on placement of a disk of an absorbent material, soaked in the shows problem, on an agar plate seeded with a Certain microbial species are the oldest. These methods allow to confirm the presence of inhibitory substances by appearance, after the corresponding incubation, of a "halo of inhibition "around the disc.
Existen diversas variantes de la técnica del "disco en placa" que difieren en el uso de diversas especies/cepas microbianas (Geobacillus stearothermohilus, Bacillus subtilis, Bacillus cereus, Bacillus megaterium, Streptococcus thermophilus, Sarcina lutea, etc.), de diversos medios y condiciones de cultivo, etc., que en general resultan útiles en situaciones concretas. Sin embargo, todas ellas presentan el inconveniente común de su laboriosidad que impide su uso sistemático para la realización de pruebas rutinarias tanto en centros oficiales de control como en los propios laboratorios de las industrias agroalimentarias.There are several variants of the "plaque disc" technique that differ in the use of various species / microbial strains ( Geobacillus stearothermohilus, Bacillus subtilis, Bacillus cereus, Bacillus megaterium, Streptococcus thermophilus, Sarcina lutea , etc.), of various media and cultivation conditions, etc., which in general are useful in specific situations. However, all of them present the common inconvenience of their industriousness that prevents their systematic use for performing routine tests both in official control centers and in the laboratories of the agri-food industries.
Para subsanar esta limitación se han lanzado al mercado diversos métodos listos para el uso basados en la detección de los cambios inducidos por la actividad metabólica de Geobacillus stearothermophilus var. calidolactis C953 en diversos medios, en presencia de la muestra problema. Se han descrito ejemplos de tales ensayos en los documentos EP 0005891, EP 0611001, US 4946777, US 3941658, ES 2176220 o ES 2153562. Por lo general, estos métodos proporcionan un resultado en un plazo de 1 ½ a 4 ½ horas mediante el cambio de color de un indicador ácido-base o redox añadido al sistema de ensayo. Permiten procesar gran número de muestras por lo que son los más utilizados en nuestros días.To overcome this limitation, various ready-to-use methods based on the detection of changes induced by the metabolic activity of Geobacillus stearothermophilus var. C953 calidolactis in various media, in the presence of the problem sample. Examples of such tests have been described in EP 0005891, EP 0611001, US 4946777, US 3941658, ES 2176220 or ES 2153562. Generally, these methods provide a result within 1½ to 4½ hours by changing color of an acid-base or redox indicator added to the test system. They allow to process large number of samples so they are the most used in our days.
Geobacillus stearothermophilus var. calidolactis C953 presenta un rápido crecimiento y la ventaja adicional de que es termófilo, es decir, que su temperatura óptima de crecimiento se encuentra entre 50 y 70°C. Estas temperaturas extremas impiden el crecimiento de posibles microorganismos contaminantes presentes en el medio de ensayo que pudieran afectar el resultado del ensayo. Además, su temperatura mínima de crecimiento es superior a 45°C, lo que permite que el método de ensayo sea estable a temperaturas de almacenamiento o temperatura ambiente. Geobacillus stearothermophilus var. Calidolactis C953 has rapid growth and the additional advantage that it is thermophilic, that is, its optimum growth temperature is between 50 and 70 ° C. These extreme temperatures prevent the growth of possible contaminating microorganisms present in the test medium that could affect the test result. In addition, its minimum growth temperature is greater than 45 ° C, which allows the test method to be stable at storage temperatures or room temperature.
Si bien la utilización de estos métodos de ensayo ofrece numerosas ventajas, también muestran algunas carencias en relación con la falta de sensibilidad a algunos grupos de antibióticos comúnmente utilizados en los tratamientos terapéuticos/profilácticos de animales destinados al consumo humano. Los métodos de ensayo basados en la inhibición del crecimiento de Geobacillus stearothermophilus var. calidolactis se muestran especialmente sensibles a antibióticos beta-lactámicos, y gracias a la adición de sustancias coadyuvantes y la modificación de las condiciones de ensayo también resultan suficientemente sensibles a tetraciclinas y sulfamidas. Sin embargo, los límites de detección que presentan frente a una gran mayoría de antibióticos aminoglucósidos y macrólidos difieren en ocasiones en varios órdenes logarítmicos de los LMRs establecidos.While the use of these test methods offers numerous advantages, they also show some shortcomings in relation to the lack of sensitivity to some groups of antibiotics commonly used in therapeutic / prophylactic treatments of animals intended for human consumption. Assay methods based on the growth inhibition of Geobacillus stearothermophilus var. Calidolactis are especially sensitive to beta-lactam antibiotics, and thanks to the addition of adjuvant substances and the modification of the test conditions they are also sufficiently sensitive to tetracyclines and sulfa drugs. However, the detection limits that they present against a large majority of aminoglycoside and macrolide antibiotics sometimes differ in several logarithmic orders from established MRLs.
La presente especificación demuestra que la utilización de Geobacillus kaustophilus como organismo de ensayo permite ampliar la gama de compuestos antimicrobianos que pueden ser detectados mediante un método rápido de ensayo listo para su uso en un periodo de tiempo inferior a 4 ½ (ver Figuras 1 y 2).This specification demonstrates that the use of Geobacillus kaustophilus as a test organism makes it possible to expand the range of antimicrobial compounds that can be detected by a rapid test method ready for use in a period of time less than 4½ (see Figures 1 and 2 ).
El método de ensayo de detección de antibióticos y otros compuestos antimicrobianos, objeto de esta memoria, reivindica la utilización de Geobacillus kaustophilus como microorganismo de ensayo de un nuevo método rápido de ensayo que permita detectar uno o varios compuestos antimicrobianos en una muestra biológica, como por ejemplo leche, huevo, carne, miel, suero u orina. Este nuevo método de ensayo comprende la puesta en contacto de la muestra problema con un microorganismo de ensayo seleccionado de entre las cepas termofilicas de Geobacillus kaustophilus, y la provisión de las condiciones de realización del ensayo en las que: en ausencia de compuestos antimicrobianos la actividad metabólica de dicho microorganismo de ensayo suceda y pueda ser detectada; y en presencia de compuestos antimicrobianos dicha actividad metabólica sea inhibida y por tanto, no pueda ser detectada.The test method of detecting antibiotics and other antimicrobial compounds, object of this report, claims the use of Geobacillus kaustophilus as a test microorganism of a new rapid test method that allows one or more antimicrobial compounds to be detected in a biological sample, such as example milk, egg, meat, honey, whey or urine. This new test method comprises contacting the test sample with a test microorganism selected from the thermophilic strains of Geobacillus kaustophilus , and the provision of the conditions for carrying out the test in which: in the absence of antimicrobial compounds the activity metabolic of said test microorganism happen and can be detected; and in the presence of antimicrobial compounds said metabolic activity is inhibited and therefore cannot be detected.
Este nuevo método de ensayo permite ampliar la gama de compuestos antimicrobianos que pueden ser detectados mediante un método rápido listo para su uso en un periodo de tiempo inferior a 4 ½ horas.This new test method allows to extend the range of antimicrobial compounds that can be detected by a quick method ready for use over a period of time less than 4½ hours.
El medio de ensayo puede ser opcionalmente un medio sólido, como por ejemplo un medio de agar, o líquido, como por ejemplo un caldo nutritivo, al que se añade el microorganismo de ensayo, los nutrientes necesarios para soportar el crecimiento de dicho microorganismo, un indicador de la actividad metabólica microbiana, tales como un indicador de pH o uno o más indicadores redox, y opcionalmente, sustancias que permitan modificar la sensibilidad a ciertos compuestos antimicrobianos. Todos estos componentes o parte de ellos pueden opcionalmente ser añadidos al medio de ensayo por separado mediante una pastilla o un disco de papel.The test medium may optionally be a solid medium, such as an agar medium, or liquid, such as for example a nutritious broth, to which the microorganism of test, the nutrients needed to support the growth of said microorganism, an indicator of metabolic activity microbial, such as a pH indicator or one or more indicators redox, and optionally, substances that allow modifying the sensitivity to certain antimicrobial compounds. All these components or part of them can optionally be added to the test medium separately using a tablet or a disc of paper.
Geobacillus kaustophilus presenta un rápido crecimiento y la ventaja adicional de que es termófilo, por lo que puede crecer a temperaturas extremas (50-70°C) impidiendo la interferencia de posibles microorganismos contaminantes que pudieran afectar al resultado del método de ensayo. Además, no puede crecer a temperatura ambiente lo que permite que el método de ensayo sea estable a temperaturas de almacenamiento hasta su uso. Geobacillus kaustophilus has rapid growth and the additional advantage that it is thermophilic, so it can grow at extreme temperatures (50-70 ° C) preventing interference from possible contaminating microorganisms that could affect the result of the test method. In addition, it cannot grow at room temperature which allows the test method to be stable at storage temperatures until use.
El microorganismo se añade preferentemente al medio de ensayo en forma de una suspensión de esporas. En función del tiempo de realización del ensayo o del grado de sensibilidad a los distintos compuestos antimicrobianos que se pretenda conseguir dicho microorganismo estará presente en una concentración de 10^{4} a 10^{9} UFC/ml.The microorganism is preferably added to the test medium in the form of a spore suspension. Function of the time of carrying out the test or the degree of sensitivity to the different antimicrobial compounds that are intended to be achieved said microorganism will be present in a concentration of 10 4 to 10 9 CFU / ml.
El microorganismo puede, o bien conservarse dispersado en un medio sólido, por ejemplo un medio de agar solidificado, líquido, por ejemplo en un caldo nutritivo, o bien puede conservarse en forma deshidratada o liofilizada.The microorganism can either be preserved dispersed in a solid medium, for example an agar medium solidified, liquid, for example in a nutrient broth, or It can be preserved in a dehydrated or lyophilized form.
El microorganismo de ensayo se activa al ponerse en contacto con la muestra problema y al ser incubado en el medio de ensayo a temperaturas entre 40 y 75°C.The test microorganism is activated when placed in contact with the problem sample and when incubated in the medium test at temperatures between 40 and 75 ° C.
Entre los nutrientes adecuados se incluyen fuentes de carbono asimilables, fuentes de nitrógeno asimilables y fuentes de factores de crecimiento y minerales.Suitable nutrients include assimilable carbon sources, assimilable nitrogen sources and sources of growth factors and minerals.
El crecimiento del microorganismo de ensayo puede detectarse o bien visualmente, o por el cambio de color del medio de ensayo en el que se encuentra presente un indicador de la actividad metabólica. Éste puede ser un indicador de pH, preferentemente púrpura de bromo-cresol, o uno o varios indicadores redox, preferentemente negro brillante.The growth of the test microorganism can be detected either visually, or by changing the color of the test medium in which an indicator of the metabolic activity This may be a pH indicator, preferably bromo-cresol purple, or one or several redox indicators, preferably gloss black.
La sensibilidad del método de ensayo puede modificarse por diversos medios: por ejemplo cambiando las condiciones de ensayo, tales como la temperatura y tiempo de incubación, o el pH del medio de ensayo, variando la relación de volúmenes del medio de detección y la sustancia a analizar, o mediante la adición de sustancias que permitan modificar la sensibilidad a ciertos compuestos antimicrobianos. Como ejemplo, se sugiere la adición de trimetoprim para incrementar la sensibilidad del método de ensayo a las sulfamidas.The sensitivity of the test method can be modified by various means: for example by changing the test conditions, such as temperature and time of incubation, or the pH of the test medium, varying the ratio of volumes of the detection medium and the substance to be analyzed, or by adding substances that allow modifying the sensitivity to certain antimicrobial compounds. As an example, it suggests the addition of trimethoprim to increase sensitivity of the sulfamide test method.
En relación con las unidades de ensayo, éstas pueden ser de distinto tamaño, entendiendo que la relación entre la cantidad de medio de detección y de la muestra problema determina la sensibilidad del método de ensayo. Así, pueden utilizarse opcionalmente tubos de entre 3-30 mm de altura y 1-20 mm de sección transversal, placas, placas de microtitulación o bloques con hendiduras tubulares que alojan el medio de ensayo. El volumen del medio de ensayo y de la muestra problema podrá variar en función de la unidad de ensayo. Por ejemplo, cuando la unidad de ensayo sea un tubo el volumen del medio de ensayo podrá oscilar entre 10 \mul y 3 ml y el volumen de la muestra problema entre 10 \mul y 1 ml.In relation to the test units, these They can be of different sizes, understanding that the relationship between amount of detection medium and sample problem determines The sensitivity of the test method. Thus, they can be used optionally tubes between 3-30 mm high and 1-20 mm cross section, plates, plates microtiter or blocks with tubular grooves that house the test medium The volume of the test medium and the sample Problem may vary depending on the test unit. By For example, when the test unit is a tube the volume of the test medium may range between 10 µl and 3 ml and the volume of the test sample between 10 µl and 1 ml.
En relación con las condiciones de realización del ensayo, la temperatura de ensayo puede estar entre 40 y 75°C, con mayor preferencia entre 60-65°C; el pH del medio de ensayo entre 5-8; y el tiempo de incubación puede ser de entre 1 ½ y 4 ½ horas.In relation to the conditions of realization of the test, the test temperature may be between 40 and 75 ° C, more preferably between 60-65 ° C; the pH of the medium test between 5-8; and the incubation time can be between 1½ and 4½ hours.
La incubación puede realizarse opcionalmente en un baño de agua, en una estufa, o en cualquier otro tipo de incubadora convencional.Incubation can optionally be performed in a water bath, in a stove, or in any other type of conventional incubator
La lectura del resultado del método de ensayo puede obtenerse visualmente u opcionalmente mediante la medida espectrofotométrica de los cambios de absorbancia experimentados por el medio de ensayo.Reading the result of the test method can be obtained visually or optionally by measurement spectrophotometric of the absorbance changes experienced by the test medium.
Figura 1.- Comparación de la sensibilidad de Geobacillus kaustophilus y Geobacillus stearothermophilus var. calidolactis C953 a diversos antibióticos y sulfamidas, determinada según el método del disco en placa. La figura representa en ordenadas el diámetro del halo de inhibición de placas de Petri inoculadas con Geobacillus kaustophilus o Geobacillus stearothermophilus var. calidolactis, causado por la presencia de un disco de papel conteniendo concentraciones conocidas de penicilina, ampicilina, cefazolina, tetraciclina, oxitetraciclina, cloranfenicol, sulfanilamida, norfloxacina, gentamicina, neomicina, polimixina o eritromicina.Figure 1.- Comparison of the sensitivity of Geobacillus kaustophilus and Geobacillus stearothermophilus var. C953 calidolactis to various antibiotics and sulfonamides, determined according to the plate disc method. The figure represents the diameter of the inhibition halo of petri dishes inoculated with Geobacillus kaustophilus or Geobacillus stearothermophilus var. calidolactis, caused by the presence of a paper disk containing known concentrations of penicillin, ampicillin, cefazolin, tetracycline, oxytetracycline, chloramphenicol, sulfanilamide, norfloxacin, gentamicin, neomycin, polymyxin or erythromycin.
Como se observa en la figura, Geobacillus kaustophilus mostró una mayor sensibilidad que Geobacillus stearothermophilus var. calidolactis a todos los compuestos antimicrobianos testados, aunque en distinta cuantía. Mientras que la sensibilidad a beta lactámicos fue similar en ambas especies, Geobacillus kaustophilus se mostró entre un 30 y un 45% más sensible que Geobacillus stearothermopnilus var calidolactis frente a tetraciclina, sulfanilamida, gentamicina, cloranfenicol, y neomicina.As seen in the figure, Geobacillus kaustophilus showed greater sensitivity than Geobacillus stearothermophilus var. calidolactis to all tested antimicrobial compounds, although in different amounts. While the sensitivity to beta-lactams was similar in both species, Geobacillus kaustophilus was between 30 and 45% more sensitive than Geobacillus stearothermopnilus var calidolactis against tetracycline, sulfanilamide, gentamicin, chloramphenicol, and neomycin.
Figura 2.- Establecimiento del límite de detección para la estreptomicina del método de ensayo basado en la inhibición del crecimiento de Geobacillus kaustophilus y realizado según la descripción de un ensayo preferente descrito en el siguiente apartado. La figura representa en abcisas el tiempo de incubación en horas y en ordenadas los cambios de absorbancia que se producen como consecuencia de la actividad metabólica del organismo de ensayo.Figure 2.- Establishment of the detection limit for streptomycin of the test method based on the inhibition of the growth of Geobacillus kaustophilus and performed according to the description of a preferred test described in the following section. The figure represents in abscissa the incubation time in hours and in ordinates the absorbance changes that occur as a result of the metabolic activity of the test organism.
Para la realización de este ensayo se utilizó una placa de microtitulación fabricada según se describe en el siguiente apartado (Descripción de un ensayo preferente). Como solución control se inoculó 0,1 ml de agua destilada, y como muestras problemas se inocularon 0,1 ml de agua destilada contaminada con 50, 100, 200, 300, 400, 600 y 1000 ppbs de estreptomicina. Todas las muestras se inocularon por cuadruplicado.To carry out this test, it was used a microtiter plate manufactured as described in the next section (Description of a preferred test). How control solution was inoculated 0.1 ml of distilled water, and as problem samples were inoculated 0.1 ml of distilled water contaminated with 50, 100, 200, 300, 400, 600 and 1000 ppbs of streptomycin. All samples were inoculated by quadruplicate.
Como se observa en la figura, el método de ensayo detectó la presencia de estreptomicina en concentraciones iguales o superiores a 200 ppb en un tiempo inferior a las 4 ½ horas.As seen in the figure, the method of trial detected the presence of streptomycin in concentrations equal to or greater than 200 ppb in a time less than 4½ hours.
Para complementar la descripción, aunque de forma ilustrativa y no limitativa, se acompaña la presente memoria de la descripción de un ensayo preferente realizado en las siguientes condiciones:To complement the description, although of Illustrative and non-limiting, this report is attached of the description of a preferred test carried out in the following conditions:
Unidad de ensayo: como placas de ensayo se utilizaron placas de microtitulación de 96 pocillos lo que nos permitió disponer de 96 unidades de ensayo independientes.Test unit: as test plates are they used 96-well microtiter plates which we allowed 96 independent test units.
Medio de ensayo: se preparó una solución de 15 g de agar, 5 g de peptona, 3 g de extracto de carne, y 1,2 g de dextrosa en 1000 ml de agua destilada. La solución final se esterilizó a 121°C durante 20 min y se enfrió hasta aproximadamente 45-50°C.Test medium: a solution of 15 g was prepared agar, 5 g peptone, 3 g meat extract, and 1.2 g of dextrose in 1000 ml of distilled water. The final solution is sterilized at 121 ° C for 20 min and cooled to approximately 45-50 ° C.
Microorganismo de ensayo: al medio de ensayo se
añadió cierto volumen de una suspensión de esporos de
Geobacillus kaustophilus en agua destilada para obtener una
concentración final de 108 esporas/
ml.Test microorganism: a volume of a suspension of Geobacillus kaustophilus spores in distilled water was added to the test medium to obtain a final concentration of 108 spores /
ml.
Indicador: se añadió cierta cantidad de una solución de negro brillante para obtener una concentración final de 200 mg por 1000 ml.Indicator: a certain amount of one was added Brilliant black solution to obtain a final concentration of 200 mg per 1000 ml.
Una vez realizada la mezcla de los componentes, 150 \mul de la solución se dispensaron en cada uno de los 96 pocillos de la placa de microtitulación en condiciones asépticas. A continuación, la placa se cerró con una lámina de aluminio y se almacenó bajo refrigeración (<7°C).Once the components have been mixed, 150 µl of the solution was dispensed in each of the 96 microtiter plate wells under aseptic conditions. TO then the plate was closed with an aluminum foil and it was stored under refrigeration (<7 ° C).
Una vez atemperada la placa de ensayo a temperatura ambiente se procedió a retirar la lámina de aluminio. A continuación se añadieron por cuadruplicado 0,1 ml de una muestra de agua destilada, y 0,1 ml de distintas soluciones de agua destilada contaminadas con 50, 100, 200, 400, 600 y 1000 ppbs de estreptomicina. Condiciones de realización del ensayo: a continuación la placa de ensayo se incubó durante 4 horas y 30 minutos en una estufa a 65°C.Once the test plate is tempered to At room temperature the aluminum foil was removed. TO then 0.1 ml of a sample was added in quadruplicate of distilled water, and 0.1 ml of different water solutions distilled contaminated with 50, 100, 200, 400, 600 and 1000 ppbs of streptomycin. Test performance conditions: a then the test plate was incubated for 4 hours and 30 minutes in an oven at 65 ° C.
Lectura de los resultados: mientras que las unidades de ensayo inoculadas con las muestras control o con las muestras contaminadas con 50 o 100 ppbs de estreptomicina viraban desde el negro original hasta adquirir una coloración anaranjada, las unidades de ensayo inoculadas con las muestras de leche fresca de vaca contaminadas con 200 ppbs o más de estreptomicina permanecían de color oscuro obteniéndose lecturas espectrofotométricas superiores al límite de detección fijado en 0,3 de absorbancia.Reading the results: while the test units inoculated with the control samples or with the samples contaminated with 50 or 100 ppbs of streptomycin viraban from the original black to acquire an orange color, test units inoculated with fresh milk samples of cow contaminated with 200 ppbs or more of streptomycin they remained dark obtaining readings spectrophotometers greater than the detection limit set at 0.3 absorbance
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200402932A ES2263361B1 (en) | 2004-11-30 | 2004-11-30 | METHOD OF DETECTION OF ANTIBIOTIC RESIDUES AND OTHER ANTIBACTERIAL COMPOUNDS. |
PCT/ES2005/000622 WO2006058936A1 (en) | 2004-11-30 | 2005-11-15 | Method of detecting antibiotic residues and other antimicrobial compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200402932A ES2263361B1 (en) | 2004-11-30 | 2004-11-30 | METHOD OF DETECTION OF ANTIBIOTIC RESIDUES AND OTHER ANTIBACTERIAL COMPOUNDS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2263361A1 true ES2263361A1 (en) | 2006-12-01 |
ES2263361B1 ES2263361B1 (en) | 2007-11-01 |
Family
ID=36564781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200402932A Active ES2263361B1 (en) | 2004-11-30 | 2004-11-30 | METHOD OF DETECTION OF ANTIBIOTIC RESIDUES AND OTHER ANTIBACTERIAL COMPOUNDS. |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2263361B1 (en) |
WO (1) | WO2006058936A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100554950C (en) * | 2007-09-29 | 2009-10-28 | 中国农业科学院上海兽医研究所 | The method of antibacterial medicine residue in a kind of rapid screening milk-like liquid sample |
CN101571541B (en) * | 2009-06-01 | 2013-10-30 | 北京望尔生物技术有限公司 | Enzyme-linked immunosorbent inspect kit for inspecting sulfa drugs and method thereof |
CN106771214A (en) * | 2016-11-30 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | Metopycide detection method and kit in a kind of poultry |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2153562T3 (en) * | 1995-02-01 | 2001-03-01 | Dsm Nv | NEW MICROBIOLOGICAL TEST METHOD. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO114686B1 (en) * | 1993-02-11 | 1999-06-30 | Gist Brocades Nv | Method for detecting antibacterial compounds in a test sample |
-
2004
- 2004-11-30 ES ES200402932A patent/ES2263361B1/en active Active
-
2005
- 2005-11-15 WO PCT/ES2005/000622 patent/WO2006058936A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2153562T3 (en) * | 1995-02-01 | 2001-03-01 | Dsm Nv | NEW MICROBIOLOGICAL TEST METHOD. |
Also Published As
Publication number | Publication date |
---|---|
WO2006058936A1 (en) | 2006-06-08 |
ES2263361B1 (en) | 2007-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Barry et al. | An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens | |
CN101790683A (en) | The composition and the device that are used for diagnosing microbial infections | |
Sabath et al. | Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other | |
CA2493870C (en) | Device and method for detecting antibiotic inactivating enzymes | |
PL184460B1 (en) | Quick microbiological test for detecting antibacterial compounds | |
ES2305912T3 (en) | MEANS TO DETECT MICROBES OBJECTIVE IN A SAMPLE. | |
Mahmud et al. | Presence of virulence factors and antibiotic resistance among Escherichia coli strains isolated from human pit sludge | |
WO2006058936A1 (en) | Method of detecting antibiotic residues and other antimicrobial compounds | |
Mian et al. | A study of bacterial profile and antibiotic susceptibility pattern found in drinking water at district Mansehra, Pakistan | |
ES2298457T3 (en) | MEANS TO DETECT MICROBES OBJECTIVE IN A SAMPLE. | |
Mokhtari et al. | Evaluating the frequency of aac (6′)-IIa, ant (2 ″)-I, intl1, and intl2 genes in aminoglycosides resistant Klebsiella pneumoniae isolates obtained from hospitalized patients in yazd, Iran | |
Olayinka et al. | Pattern of resistance to vancomycin and other antimicrobial agents in staphylococcal isolates in a University Teaching Hospital | |
Heß et al. | Growth behavior of E. coli, Enterococcus and Staphylococcus species in the presence and absence of sub-inhibitory antibiotic concentrations: Consequences for interpretation of culture-based data | |
ES2256048T3 (en) | TEST A STEP TO DETECT ANTI-MICROBIAL WASTE IN EGGS. | |
AU2014261436B2 (en) | Method for the determination of the presence of an antibiotic in a fluid | |
WO2002020829A1 (en) | Culture medium and method for identifying gram-negative microorganisms | |
ES2818374T3 (en) | Method of neutralizing antibiotics in a culture medium | |
US8026093B2 (en) | Particulate substrates for improved recovery of microbes | |
Tula et al. | Prevalence of antibiotic resistant and biofilm producing Escherichia coli and Salmonella spp from two sources of water in Mubi, Nigeria | |
Shanahan et al. | The global impact of antibiotic-resistant bacteria: their sources and reservoirs | |
Shekhar et al. | Microbiological quality of raw milk and its public health significance | |
ES2326948B1 (en) | METHOD OF DETECTION OF QUINOLONES IN FOODS AND BIOLOGICAL MATERIALS. | |
Odu et al. | Resistance Profiles of Bacteria Isolated from Wastewater in the State Specialist Hospital Maiduguri | |
Fashina et al. | Antimicrobial Susceptibility Pattern of Enterohaemorrhagic Escherichia coli (EHEC O157: H7) in Raw Beef samples collected from abattoirs and Meat Vendors in Ile Ife and its environs, South-West, Nigeria | |
Sabath | Rapid assay of some nephrotoxic antibiotics and the assay of antibiotics in mixtures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20061201 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2263361B1 Country of ref document: ES |